The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls
Authors:
- Luca ValentiLVLuca Valenti
- Raffaela RamettaRRRaffaela Rametta
- Massimiliano RuscicaMassimiliano Ruscica
- Paola DongiovanniPaola Dongiovanni
- Liliana SteffaniLSLiliana Steffani
- Benedetta Maria MottaBMBenedetta Maria Motta
- Elena CanavesiECElena Canavesi
- Anna Ludovica FracanzaniAnna Ludovica Fracanzani
- Enrico MozziEMEnrico Mozzi
- Giancarlo RoviaroGRGiancarlo Roviaro
- Paolo MagniPaolo Magni
- Silvia FargionSFSilvia Fargion
Open Access
- 16 August 2012
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 111
Abstract
Reduced adiponectin is implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), and the I148M Patatin-like phospholipase domain-containing 3 (PNPLA3) polymorphism predisposes to NAFLD and liver damage progression in NASH and chronic hepatitis C (CHC) by still undefined mechanisms, possibly involving regulation of adipose tissue function. Aim of this study was to evaluate whether the I148M PNPLA3 polymorphism influences serum adiponectin in liver diseases and healthy controls. To this end, we considered 144 consecutive Italian patients with NAFLD, 261 with CHC, 35 severely obese subjects, and 257 healthy controls with very low probability of steatosis, all with complete clinical and genetic characterization, including adiponectin (ADIPOQ) genotype. PNPLA3 rs738409 (I148M) and ADIPOQ genotypes were evaluated by Taqman assays, serum adiponectin by ELISA. Adiponectin mRNA levels were evaluated by quantitative real-time PCR in the visceral adipose tissue (VAT) of 35 obese subjects undergoing bariatric surgery. Adiponectin levels were independently associated with the risk of NAFLD and with the histological severity of the disease. Adiponectin levels decreased with the number of 148 M PNPLA3 alleles at risk of NASH both in patients with NAFLD (p = 0.03), and in healthy subjects (p = 0.04). At multivariate analysis, PNPLA3 148 M alleles were associated with low adiponectin levels (ADIPOQ genotype (OR 1.67, 95% c.i. 1.07-2.1 for each 148 M allele). The p.148 M PNPLA3 variant was associated with decreased adiponectin mRNA levels in the VAT of obese patients (p < 0.05) even in the absence of NASH. In contrast, in CHC, characterized by adiponectin resistance, low adiponectin was associated with male gender and steatosis, but not with PNPLA3 and ADIPOQ genotypes and viral features. The I148M PNPLA3 variant is associated with adiponectin levels in patients with NAFLD and in healthy subjects, but in the presence of adiponectin resistance not in CHC patients. The I148M PNPLA3 genotype may represent a genetic determinant of serum adiponectin levels. Modulation of serum adiponectin might be involved in mediating the susceptibility to steatosis, NASH, and hepatocellular carcinoma in carriers of the 148 M PNPLA3 variant without CHC, with potential therapeutic implications.Keywords
This publication has 42 references indexed in Scilit:
- Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M VariantPLOS ONE, 2012
- Genome-Wide Association Analysis of Soluble ICAM-1 Concentration Reveals Novel Associations at the NFKBIK, PNPLA3, RELA, and SH2B3 LociPLOS Genetics, 2011
- A Common Variant in the Patatin-Like Phospholipase 3 Gene ( PNPLA3 ) Is Associated with Fatty Liver Disease in Obese Children and AdolescentsHepatology, 2010
- Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease†,‡Hepatology, 2010
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride HydrolysisJournal of Biological Chemistry, 2010
- A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin LevelsPLOS Genetics, 2009
- Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS StudObesity, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin ProductionPLOS ONE, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005